We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$3.1M
Cap. Flow
+$30.4M
Cap. Flow %
25.24%
Top 10 Hldgs %
19.44%
Holding
209
New
93
Increased
10
Reduced
42
Closed
64

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$3.43M
2
JPM icon
JPMorgan Chase
JPM
+$2.49M
3
V icon
Visa
V
+$2.46M
4
PFE icon
Pfizer
PFE
+$2.46M
5
ADI icon
Analog Devices
ADI
+$1.93M

Top Sells

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$1.28M
2
LYB icon
LyondellBasell Industries
LYB
+$1.25M
3
FAST icon
Fastenal
FAST
+$1.23M
4
QCOM icon
Qualcomm
QCOM
+$1.21M
5
OXY icon
Occidental Petroleum
OXY
+$1.19M

Sector Composition

Rank Sector Weight
1 Technology 19.77%
2 Financials 18.53%
3 Energy 14.69%
4 Industrials 14.26%
5 Healthcare 13.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAR icon
176
Interparfums
IPAR
$3.84B
-13,131
Closed -$958K
LSTR icon
177
Landstar System
LSTR
$6.03B
-6,946
Closed -$1.01M
LYB icon
178
LyondellBasell Industries
LYB
$20.7B
-14,263
Closed -$1.25M
MBUU icon
179
Malibu Boats
MBUU
$583M
-19,184
Closed -$1.01M
MHK icon
180
Mohawk Industries
MHK
$9.26B
-7,960
Closed -$987K
MRC
181
DELISTED
MRC Global
MRC
-97,852
Closed -$973K
MRVL icon
182
Marvell Technology
MRVL
$191B
-24,782
Closed -$1.08M
MTDR icon
183
Matador Resources
MTDR
$6.51B
-19,416
Closed -$903K
MXL icon
184
MaxLinear
MXL
$6.26B
-27,891
Closed -$946K
OC icon
185
Owens Corning
OC
$12.6B
-12,852
Closed -$954K
OCSL icon
186
Oaktree Specialty Lending
OCSL
$1.13B
-53,739
Closed -$1.05M
OXY icon
187
Occidental Petroleum
OXY
$59B
-20,293
Closed -$1.19M
PANW icon
188
Palo Alto Networks
PANW
$313B
-11,082
Closed -$911K
PKG icon
189
Packaging Corp of America
PKG
$22.9B
-7,211
Closed -$991K
QCOM icon
190
Qualcomm
QCOM
$171B
-9,456
Closed -$1.21M
RVTY icon
191
Revvity
RVTY
$12.9B
-9,009
Closed -$1.28M
SAIA icon
192
Saia
SAIA
$9.52B
-4,405
Closed -$827K
SBLK icon
193
Star Bulk Carriers
SBLK
$3.09B
-37,399
Closed -$933K
SNDR icon
194
Schneider National
SNDR
$6.12B
-45,983
Closed -$1.03M
SNV
195
DELISTED
Synovus
SNV
-27,547
Closed -$992K
SPY icon
196
State Street SPDR S&P 500 ETF Trust
SPY
$807B
-2,619
Closed -$1.04M
TWI icon
197
Titan International
TWI
$461M
-63,061
Closed -$951K
TXRH icon
198
Texas Roadhouse
TXRH
$13.8B
-14,145
Closed -$1.03M
WGO icon
199
Winnebago Industries
WGO
$927M
-18,358
Closed -$890K
WLK icon
200
Westlake Corp
WLK
$10.3B
-9,535
Closed -$933K

Similar funds

Alpha DNA Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Alpha DNA Investment Management held 209 positions worth $120M, up 2.6% from $117M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alpha DNA Investment Management deployed $30.4M of net new capital in Q3 2022, opening 93 new positions and adding to 10 existing holdings. Its largest new stake was ExxonMobil: 37,550 shares worth $3.28M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $988K trimmed.

  • Alpha DNA Investment Management's largest Q3 2022 buy was ExxonMobil: 37,550 shares worth $3.28M.
  • Alpha DNA Investment Management added most to Analog Devices in Q3 2022, an estimated $1.93M increase.
  • Alpha DNA Investment Management's biggest Q3 2022 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $988K.
  • Alpha DNA Investment Management fully exited Revvity in Q3 2022, selling an estimated $1.28M.
  • Alpha DNA Investment Management's ten largest holdings make up 19% of its $120M portfolio in Q3 2022.
  • Alpha DNA Investment Management opened 93 new positions and closed 64 in Q3 2022.
  • Alpha DNA Investment Management's portfolio value rose 2.6% quarter-over-quarter to $120M.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.